RADX

Radiopharm Theranostics

RADX

Market cap $40.9M

Upgrade to unlock

Positive

Neutral

Negative

Sentiment 3-Months

Positive

Neutral 50%

Negative

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Limited (NASDAQ: RADX) stock is trading higher on Monday, with a session volume of 21.33 million compared to the average volume of 26.81 thousand, as per data from Benzinga Pro.

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent brain metastases

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

See News Rankings